Advertisement

Topics

Genentech gets FDA nod for Actemra

04:56 EDT 31 Aug 2017 | SmartBrief

Genentech's Actemra, or tocilizumab, which is indicated for the treatment of patients with CAR-T cell-induced cytokine releas -More

Original Article: Genentech gets FDA nod for Actemra

NEXT ARTICLE

More From BioPortfolio on "Genentech gets FDA nod for Actemra"

Quick Search
Advertisement
 

Relevant Topic

Cytokine
Cytokines include chemokines, lymphokines, and monokines. Cells of the immune system communicate with one another by releasing and responding to chemical messengers called cytokines. These proteins are secreted by immune cells and act on other cells to...